title: Dual cocaine and methamphetamine cardiovascular toxicity: rapid resolution with labetalol.
authors.affiliation: Department of Emergency Medicine, University of California Davis Medical Center, Sacramento, CA. Electronic address: jrrichards@ucdavis.edu.
authors.forename: John R
authors.initials: JR
authors.lastname: Richards
authors.affiliation: Texas Tech University Health Sciences Center, Department of Internal Medicine, Division of Cardiology, El Paso, TX.
authors.forename: Richard A
authors.initials: RA
authors.lastname: Lange
authors.affiliation: Department of Emergency Medicine, Louisiana State University Health Sciences Center, Louisiana Poison Center, Shreveport, LA.
authors.forename: Thomas C
authors.initials: TC
authors.lastname: Arnold
authors.affiliation: Department of Emergency Medicine, Oregon Health Sciences University, Oregon Poison Center, Portland, OR.
authors.forename: B Zane
authors.initials: BZ
authors.lastname: Horowitz
mesh_terms: D061605:Administration, Intravenous; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use; D019969:Amphetamine-Related Disorders / Q000150:complications; D014151:Anti-Anxiety Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D001007:Anxiety / Q000139:chemically induced / Q000188:drug therapy; D002318:Cardiovascular Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D002319:Cardiovascular System / Q000187:drug effects*; D000697:Central Nervous System Stimulants / Q000494:pharmacology / Q000633:toxicity; D002637:Chest Pain / Q000139:chemically induced / Q000175:diagnosis; D003042:Cocaine / Q000633:toxicity*; D019970:Cocaine-Related Disorders / Q000150:complications; D004347:Drug Interactions; D004562:Electrocardiography; D006801:Humans; D006945:Hyperhidrosis / Q000139:chemically induced / Q000188:drug therapy; D007741:Labetalol / Q000008:administration & dosage* / Q000627:therapeutic use; D008140:Lorazepam / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D008694:Methamphetamine / Q000494:pharmacology / Q000633:toxicity*; D012965:Sodium Chloride / Q000008:administration & dosage / Q000627:therapeutic use; D013610:Tachycardia / Q000139:chemically induced / Q000175:diagnosis; D055815:Young Adult
chemical_list: D000319:Adrenergic beta-Antagonists; D014151:Anti-Anxiety Agents; D000697:Central Nervous System Stimulants; D008694:Methamphetamine; D012965:Sodium Chloride; D003042:Cocaine; D008140:Lorazepam; D007741:Labetalol